MARKET

PFE

PFE

Pfizer
NYSE
25.40
+0.14
+0.55%
After Hours: 25.44 +0.04 +0.16% 19:59 04/26 EDT
OPEN
25.33
PREV CLOSE
25.26
HIGH
25.54
LOW
25.20
VOLUME
46.53M
TURNOVER
0
52 WEEK HIGH
40.37
52 WEEK LOW
25.20
MARKET CAP
143.83B
P/E (TTM)
68.43
1D
5D
1M
3M
1Y
5Y
S&P 500 Earnings: The Upward Revisions Are A Big Positive
The S&P 500 earnings yield ended the week above 5% for the first time since January 19th. The "upside surprise" for this quarter's earnings was 9.5%. The upside revenue surprise was 1.3% through this week. This is the 5th week in a row of sequentially higher estimates for the S&p 500.
Seeking Alpha · 11h ago
After Hours Most Active for Apr 26, 2024 : SNAP, PFE, VZ, BAC, T, AAPL, JCI, CSCO, AMZN, MSFT, SQQQ, GOOGL
NASDAQ · 15h ago
Diving Into Deciphera Pharmaceuticals
Shares of Deciphera Pharmaceuticals, Inc. Have rallied 40% since October after positive trial data for vimseltinib in the treatment of TGCT. Vimsel tinib is expected to make significant progress in the TGCT indication. The company's switch-control kinase inhibitor platform aims to produce compounds that target specific regions of kinases.
Seeking Alpha · 15h ago
Catalyst Watch: Apple earnings, Viking IPO, Chinese EV deliveries and Russell indices' Rank Day
Seeking Alpha's Catalyst Watch includes a look at next week's key events. The Russell indices' ranking day will be used for the reconstitution of the firm's U.S. Indexes on April 26, 2024. Shares of Tesla will update monthly deliveries of electric vehicles in China. Apple's earnings and Viking's IPO are the focus of the week.
Seeking Alpha · 16h ago
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
Acuitas Therapeutics and Germany-based CureVac NV have settled a lawsuit over credit for inventions tied to COVID-19 vaccines. Acuitas accused CureVAC of failing to credit it on patents related to the technology used in the vaccines. The company has previously secured a separate license for the technology employed in the vaccine.
Benzinga · 16h ago
What to Watch in the Week Ahead and on Monday, April 29
Domino's Pizza expected to post a rise in first-quarter revenue on resilient demand for its pizzas. Apple's revenue is expected to decline 5% in the week. The U.S. Economic calendar has a flurry of data due in the next few days.
Reuters · 16h ago
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
FDA approves Pfizer's Beqvez for moderate to severe hemophilia B in adult patients. The treatment is a one-time treatment designed to enable patients to produce FIX themselves. Pfizer is launching a warranty program based on the durability of patient response to treatment. The approval is based on a study of 60% of patients.
Benzinga · 17h ago
More than half of the S&P 500 names that reported results this week beat top and bottom line - Earnings Scorecard
More than half of the S&P 500 names that reported results this week beat top and bottom line. Of the 156 companies that reported, 125 had EPS above analyst expectations, 28 missed consensus, and three were in line. This week was one of the heaviest in terms of companies reporting their first quarter earnings.
Seeking Alpha · 17h ago
More
About PFE
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its Oncology products include Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak. Its primary care products include Eliquis, Nurtec ODT/Vydura, Comirnaty, the Prevnar family, Abrysvo, FSME/IMMUN-TicoVac, Paxlovid and Lucira by Pfizer. Its specialty care products include Xeljanz, Enbrel (outside the U.S. and Canada), Inflectra, Cibinqo, Litfulo, Vyndaqel family, Genotropin, Sulperazon, Zavicefta, Medrol and Panzyga.

Webull offers Pfizer Inc stock information, including NYSE: PFE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PFE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PFE stock methods without spending real money on the virtual paper trading platform.